... the range of options, which will be available at different times, has left people wondering which vaccines to take, and when. “These are hard questions, and there are no real right answers,” says Kathryn Edwards, a paediatrician and director of the Vanderbilt Vaccine Research Program at Vanderbilt University Medical Center in Nashville, Tennessee.
Nature asked specialists what evidence is on hand to help make the decision. ...
Data collected from two vaccine safety surveillance programs in the first 10 weeks of administration of third doses of the Pfizer/BioNTech COVID-19 to US children aged 5 to 11 years show that serious adverse events were rare.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/DHUNX5ALMNPTBGMMZFKISAU2OE.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/RQYR3MG57BPH5MBLQJD4F7US5A.jpg)
